Combinostics at ECR 2022

13-17 July 2022  |  Vienna, Austria
Booth AI-09

Did you miss our team at the 2022 European Congress of Radiology (ECR) or want to discuss our products further? Schedule some time to learn more about our cNeuro® suite, including the cMRI™ and cDSI™ applications, industry-first Dementia Differential Analysis report, and new clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy. Our complete AI software solution supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring. 

Our presentations at ECR 2022

Presenter: Peter Ngum, Clinical Application Specialist
Friday, July 15 | 11:20 – 11:26 CEST

Differential diagnosis of dementias: MRI only diagnostic trend to enable differentiation with imaging alone

Location: AI Theatre
Saturday, July 16 | 10:30 – 11:30 CEST

Validation of automated MS lesion detection in two
independent cohorts

RPS 1811: Advanced neuroimaging in various diseases

Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.

Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.

Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests. 

Applications in the cNeuro® suite:

*WIP – not yet cleared for clinical use.
Play Video
Play Video


Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.


cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.

Play Video

Dementia Differential Analysis report

The new Dementia Differential Analysis report is based on MRI data only, using our cDSI application’s proprietary machine learning method that measures the similarity of disease-specific imaging biomarker values from the patient to those from 2,000+ patients with a confirmed neurodegenerative disease:

Clinically focused cMRI reports

Our new clinically focused cMRI reports facilitate patient management as well as communication between radiologists, neurologists, patients, and their caregivers. These include reports for: